- Home
- ALKS vs ACT Comparison
ALKS vs ACT Comparison
Compare ALKS & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- ACT
- Stock Information
- Founded
- ALKS 1987
- ACT 1981
- Country
- ALKS Ireland
- ACT United States
- Employees
- ALKS N/A
- ACT N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- ACT Specialty Insurers
- Sector
- ALKS Health Care
- ACT Finance
- Exchange
- ALKS Nasdaq
- ACT Nasdaq
- Market Cap
- ALKS 5.0B
- ACT 5.5B
- IPO Year
- ALKS 1991
- ACT 2021
- Fundamental
- Price
- ALKS $29.21
- ACT $35.63
- Analyst Decision
- ALKS Strong Buy
- ACT Hold
- Analyst Count
- ALKS 13
- ACT 3
- Target Price
- ALKS $42.54
- ACT $39.00
- AVG Volume (30 Days)
- ALKS 2.1M
- ACT 317.2K
- Earning Date
- ALKS 10-28-2025
- ACT 11-05-2025
- Dividend Yield
- ALKS N/A
- ACT 2.35%
- EPS Growth
- ALKS 21.99
- ACT 6.06
- EPS
- ALKS 2.08
- ACT 4.41
- Revenue
- ALKS $1,505,296,000.00
- ACT $1,223,030,000.00
- Revenue This Year
- ALKS N/A
- ACT $4.10
- Revenue Next Year
- ALKS $1.59
- ACT $3.52
- P/E Ratio
- ALKS $14.32
- ACT $8.11
- Revenue Growth
- ALKS N/A
- ACT 3.15
- 52 Week Low
- ALKS $25.17
- ACT $30.79
- 52 Week High
- ALKS $36.45
- ACT $39.47
- Technical
- Relative Strength Index (RSI)
- ALKS 42.95
- ACT 41.48
- Support Level
- ALKS $29.94
- ACT $34.87
- Resistance Level
- ALKS $32.02
- ACT $36.94
- Average True Range (ATR)
- ALKS 1.13
- ACT 0.60
- MACD
- ALKS -0.32
- ACT 0.04
- Stochastic Oscillator
- ALKS 9.12
- ACT 36.47
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.